Anti-Pan-pY/pTyr/Phosphotyrosine Antibody (4G10) from ProteoGenix; catalogue ARO-A15233; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Anti-Pan-pY/pTyr/Phosphotyrosine Antibody (4G10) is a highly specific and sensitive antibody that targets phosphorylated tyrosine residues in proteins. This antibody is widely used in research and has potential therapeutic applications due to its ability to detect and inhibit aberrant tyrosine phosphorylation, which is a hallmark of many diseases including cancer and autoimmune disorders.
Anti-Pan-pY/pTyr/Phosphotyrosine Antibody (4G10) is a monoclonal antibody, meaning it is produced by a single type of immune cell. It is derived from a hybridoma cell line, which is created by fusing a specific antibody-producing immune cell with a cancer cell. This fusion results in a stable cell line that can continuously produce large quantities of the desired antibody.
The 4G10 antibody is composed of two heavy chains and two light chains, each with a specific amino acid sequence that gives the antibody its unique structure. The heavy chains contain a constant region and a variable region, while the light chains only have a variable region. The variable regions of the heavy and light chains come together to form the antigen-binding site, which is responsible for the antibody’s specificity towards phosphorylated tyrosine residues.
Anti-Pan-pY/pTyr/Phosphotyrosine Antibody (4G10) is highly specific for phosphorylated tyrosine residues and does not bind to unphosphorylated tyrosine or any other amino acid. This specificity makes it a valuable tool for detecting and quantifying tyrosine phosphorylation in proteins. The antibody can be used in various techniques such as Western blotting, immunoprecipitation, and immunofluorescence.
In Western blotting, the 4G10 antibody is used to detect the presence of phosphorylated tyrosine residues in a protein sample. The antibody binds to the phosphorylated tyrosine residues and can be visualized using a secondary antibody that is conjugated to a detection molecule such as a fluorescent dye or an enzyme.
In immunoprecipitation, the 4G10 antibody is used to isolate and purify proteins that are phosphorylated on tyrosine residues. The antibody binds to the phosphorylated proteins and can be separated from the rest of the sample using techniques such as magnetic beads or agarose beads.
In immunofluorescence, the 4G10 antibody is used to visualize the localization of tyrosine phosphorylation in cells. The antibody can be directly conjugated to a fluorescent dye, allowing for the detection of phosphorylated proteins within the cell.
Aberrant tyrosine phosphorylation has been linked to various diseases, including cancer, autoimmune disorders, and neurodegenerative diseases. Therefore, targeting tyrosine phosphorylation has emerged as a potential therapeutic strategy for these diseases.
Anti-Pan-pY/pTyr/Phosphotyrosine Antibody (4G10) can serve as a therapeutic target by inhibiting the activity of tyrosine kinases, enzymes that catalyze the phosphorylation of tyrosine residues. By binding to the phosphorylated tyrosine residues, the antibody can block the interaction between the tyrosine kinase and its substrate, thereby inhibiting the phosphorylation process.
Moreover, the 4G10 antibody can also be used in combination with other therapeutic agents, such as small molecule inhibitors, to enhance their efficacy. This combination therapy approach can potentially lead to more effective treatment options for diseases driven by aberrant tyrosine phosphorylation.
Anti-Pan-pY/pTyr/Phosphotyrosine Antibody (4G10) is widely used in research to study tyrosine phosphorylation and its role in various cellular processes. The antibody has been used in numerous studies to investigate the signaling pathways involved in diseases such as cancer and autoimmune disorders.
ProteoGenix catalogue number ARO-A15233. For research use only.
Target: Anti-Broad-Spectrum Monoclonal Antibody; Host: mouse; Clonality: Monoclonal Antibody; Reactivity: Anti-Broad-Spectrum Monoclonal Antibody, Broad-Spectrum; Applications: IHC, IP, WB.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Species | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| Anti-Broad-Spectrum Monoclonal Antibody | |||||||||
| Broad-Spectrum |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.